Feasibility Study of Exercise in Patients With Leg Blood Clots
EXPERT
EXPERT Trial: Exercise to Prevent Post-thrombotic Syndrome Elicited by Recent Thrombosis
2 other identifiers
interventional
5
1 country
1
Brief Summary
The purpose of this pilot study is to assess the feasibility of determining the effects of a structured exercise program started two to four weeks after diagnosis of a first episode lower-extremity deep vein thrombosis (DVT) for a period of 12 weeks in reducing the incidence of post-thrombotic syndrome (PTS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 28, 2009
CompletedFirst Posted
Study publicly available on registry
May 29, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedApril 13, 2017
April 1, 2017
4.2 years
May 28, 2009
April 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Villalta PTS score
at 26 weeks
Secondary Outcomes (1)
PTS, venous valvular reflux, VEINES, MOS SF-36, maximal treadmill test, 6-minute walk, and blood analysis
at 12 weeks
Study Arms (1)
Exercise testing
EXPERIMENTALFeasibility study; all participants receive intervention
Interventions
Eligibility Criteria
You may qualify if:
- First episode lower extremity DVT (proximal or distal) documented by ultrasound, CT angiogram or venogram within last 4 weeks.
- Treatment with LMWH, or unfractionated heparin (UFH) followed by warfarin adjusted to keep INR 2 to 3 for at least 3 months, or LMWH given in therapeutic doses as sole therapy.
- Age 21 to 75 years old.
You may not qualify if:
- Recurrent DVT.
- Treatment of DVT with systemic or catheter-directed thrombolysis Contraindications to exercise training according to the American College of Sports Medicine (e.g., acute myocardial infarction, unstable angina, etc.,).
- Life expectancy \< 1 year.
- Pregnancy.
- Geographic inaccessibility.
- Cognitive dysfunction assessed by mini-mental status exam (score \< 24).
- Inability to walk.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suman W. Rathbun, M.D.
Oklahoma University Health Sciences Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
May 28, 2009
First Posted
May 29, 2009
Study Start
October 1, 2008
Primary Completion
December 1, 2012
Study Completion
December 1, 2016
Last Updated
April 13, 2017
Record last verified: 2017-04